… JMP Securities Life Sciences Conference ProQR is participating in the JMP Securities Life Sciences … 2021. Qui, 17/06/2021 - 21:00 - Qui, 17/06/2021 - 21:25 ProQR's participation in the JMP Securities investor …
… Series – Usher Syndrome and Retinitis Pigmentosa ProQR Expert Perspectives Series on Usher Syndrome and … Pigmentosa with Aniz Girach, MD, Chief Medical Officer of ProQR Therapeutics, and Robert Koenekoop, MD, PhD of McGill … link . Seg, 22/06/2020 - 12:00 - Seg, 22/06/2020 - 13:00 ProQR Expert Perspectives Series on Usher Syndrome and …
Development of RNA Base Editing Technologies for Precision Medicines with Axiomer® and Trident® presented at TIDES USA 2022 by Gerard Platenburg - ProQR Therapeutics.
